Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression

CRC Kouakou, TG Poder - The European Journal of Health Economics, 2022 - Springer
The use of a threshold for cost-utility studies is of major importance to health authorities for
making the best allocation decisions for limited resources. Regarding the increasing number …

A systematic review on the direct approach to elicit the demand-side cost-effectiveness threshold: Implications for low-and middle-income countries

A Nu Vu, MV Hoang, L Lindholm, KG Sahlen… - Plos one, 2024 - journals.plos.org
Several literature review studies have been conducted on cost-effectiveness threshold
values. However, only a few are systematic literature reviews, and most did not investigate …

Estimating the monetary value of a quality-adjusted life-year in Quebec

CRC Kouakou, J He, TG Poder - The European Journal of Health …, 2024 - Springer
Background The value of a Quality-Adjusted Life-Year (QALY) is of great importance for the
healthcare system. It helps when it comes to defining a cost-effectiveness threshold for the …

Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review

O Ben-Aharon, G Iskrov, I Sagy… - Expert review of …, 2023 - Taylor & Francis
Introduction Willingness to pay (WTP) studies examine the maximum amount of money an
individual is willing to pay for a specified health intervention, and can be used to inform …

Willingness-to-pay for cancer treatment and outcome: a systematic review

ASJ Yong, YH Lim, MWL Cheong, E Hamzah… - The European Journal of …, 2022 - Springer
Background Understanding patient preferences in cancer management is essential for
shared decision-making. Patient or societal willingness-to-pay (WTP) for desired outcomes …

Estimation of the value of curative therapies in oncology: a willingness-to-pay study in China

L Huang, X Peng, L Sun, D Zhang - Cost Effectiveness and Resource …, 2023 - Springer
The objective of this study was to estimate the willingness to pay (WTP) per quality-adjusted
life year (QALY) among people with malignancies in China. The WTP for a QALY was …

Willingness to pay for an mRNA-based anti-cancer treatment: results from a contingent valuation study in Israel

O Ben-Aharon, R Sergienko, G Iskrov… - Israel Journal of Health …, 2024 - Springer
Background mRNA technology is currently being investigated for a range of oncology
indications. We assessed the willingness to pay (WTP) of the general population in Israel for …

Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method

Q Peng, Y Yin, M Liang, M Zhao, T Shao… - Cost Effectiveness and …, 2023 - Springer
Objectives Monetizing health has sparked controversy and has implications for pricing
strategies of emerging health technologies. Medical insurance payers typically set up …

Cost-effectiveness of consolidation durvalumab for inoperable stage III non-small cell lung cancer in Vietnam

VQ Mai, L Lindholm, H Van Minh, S Sun, KB Giang… - BMJ open, 2024 - bmjopen.bmj.com
Background This study aimed to assess the cost-effectiveness of durvalumab as a treatment
option for patients with inoperable stage III non-small cell lung cancer (NSCLC) from …

Real-world treatment patterns and clinical outcomes in patients with stage III non-small-cell lung cancer: results of KINDLE-vietnam cohort

T Van Dao, TB Diep, T Le Phuong… - Frontiers in …, 2022 - frontiersin.org
Objective KINDLE-Vietnam was a part of a real-world KINDLE study with an aim to
characterise treatment patterns and clinical outcomes of patients with stage III non-small cell …